In a world-first decision, the TGA has created a Schedule 8 listing for psilocybin and MDMA. But how will this decision impact pharmacists?

The Therapeutic Goods Administration issued an alert over a commonly used of broad-spectrum class of antibiotics.

New year, new policy and practice changes. Here’s what pharmacists will need to navigate from January. In 2026, pharmacists can expect some changes to education,...

Sorry, this content is only available to users that the PSA have verified as healthcare professionals. To learn more, talk to a PSA membership...

Pharmacists on the frontline discuss a dip in AstraZeneca demand and the outcome of an erroneous announcement about the Pfizer vaccine.

Several regulatory, funding and accreditation changes will land on 1 October 2026. AP breaks down what pharmacists need to know.